These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10996197)

  • 21. Norepinephrine-stimulated increase in Na+, K+-ATPase activity in the rat brain is mediated through alpha1A-adrenoceptor possibly by dephosphorylation of the enzyme.
    Mallick BN; Adya HV; Faisal M
    J Neurochem; 2000 Apr; 74(4):1574-8. PubMed ID: 10737614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
    Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
    Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.
    Schaefer A; Magócsi M; Fandrich A; Marquardt H
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):505-11. PubMed ID: 9794788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcineurin regulates slow myosin, but not fast myosin or metabolic enzymes, during fast-to-slow transformation in rabbit skeletal muscle cell culture.
    Meissner JD; Gros G; Scheibe RJ; Scholz M; Kubis HP
    J Physiol; 2001 May; 533(Pt 1):215-26. PubMed ID: 11351029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.
    Batiuk TD; Kung L; Halloran PF
    J Clin Invest; 1997 Oct; 100(7):1894-901. PubMed ID: 9312192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin.
    Lotem J; Kama R; Sachs L
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12016-20. PubMed ID: 10518568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.
    Flörcken A; Kopp J; Kölsch U; Meisel C; Dörken B; Pezzutto A; Westermann J
    Hum Vaccin Immunother; 2016 May; 12(5):1117-23. PubMed ID: 26864050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia.
    Grünebach F; Mirakaj V; Mirakaj V; Müller MR; Brümmendorf T; Brossart P
    Cancer Res; 2006 Jun; 66(11):5892-900. PubMed ID: 16740729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transcription factor IRF8 counteracts BCR-ABL to rescue dendritic cell development in chronic myelogenous leukemia.
    Watanabe T; Hotta C; Koizumi S; Miyashita K; Nakabayashi J; Kurotaki D; Sato GR; Yamamoto M; Nakazawa M; Fujita H; Sakai R; Fujisawa S; Nishiyama A; Ikezawa Z; Aihara M; Ishigatsubo Y; Tamura T
    Cancer Res; 2013 Nov; 73(22):6642-53. PubMed ID: 24242069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-dependent expression of TNF-alpha in neural cells is mediated by the calcineurin/NFAT pathway.
    Canellada A; Cano E; Sánchez-Ruiloba L; Zafra F; Redondo JM
    Mol Cell Neurosci; 2006 Apr; 31(4):692-701. PubMed ID: 16458016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells.
    Smit WM; Rijnbeek M; van Bergen CA; de Paus RA; Vervenne HA; van de Keur M; Willemze R; Falkenburg JH
    Hum Immunol; 1997 Apr; 53(2):216-23. PubMed ID: 9129981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The enhancing effect of calcium ionophore A23187 on the accessory function of mouse dendritic cells].
    Liu C; Zhang Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):176-80. PubMed ID: 1831721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on A23187 inducing HL-60 cells to differentiate into dendritic cells].
    Yang K; Li Q; Zhao YN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):209-12. PubMed ID: 17441331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
    Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
    Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of Imatinib mesylate on the development of dendritic cells derived from bone marrow mononuclear cells of patients with chronic myeloid leukemia].
    Zheng SE; Jin J; Tong XM
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2252-5. PubMed ID: 17064569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
    Eisendle K; Lang A; Eibl B; Nachbaur D; Glassl H; Fiegl M; Thaler J; Gastl G
    Br J Haematol; 2003 Jan; 120(1):63-73. PubMed ID: 12492578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.